NOVOCURE LTD's ticker is and the CUSIP is G6674U908. A total of 5 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,760 | -61.1% | 2,400 | 0.0% | 0.00% | – |
| Q2 2023 | $99,600 | -30.8% | 2,400 | 0.0% | 0.00% | – |
| Q1 2023 | $144,000 | +4654.0% | 2,400 | -94.2% | 0.00% | – |
| Q4 2022 | $3,029 | -99.9% | 41,300 | +36.8% | 0.00% | – |
| Q3 2022 | $2,295,000 | +9.3% | 30,200 | 0.0% | 0.00% | – |
| Q2 2022 | $2,099,000 | -53.0% | 30,200 | -44.0% | 0.00% | -100.0% |
| Q1 2022 | $4,466,000 | -58.6% | 53,900 | -13.6% | 0.00% | -50.0% |
| Q4 2020 | $10,798,000 | +701.6% | 62,400 | +212.0% | 0.00% | – |
| Q1 2020 | $1,347,000 | -85.9% | 20,000 | -82.3% | 0.00% | -100.0% |
| Q4 2019 | $9,523,000 | -21.9% | 113,000 | -30.7% | 0.00% | 0.0% |
| Q3 2019 | $12,189,000 | +22.9% | 163,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $9,919,000 | +26.3% | 163,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $7,852,000 | +43.9% | 163,000 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $5,457,000 | +247.1% | 163,000 | +443.3% | 0.00% | – |
| Q3 2018 | $1,572,000 | – | 30,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 210,100 | $17,407,000 | 0.02% |
| HBK INVESTMENTS L P | 13,500 | $1,118,000 | 0.01% |
| SIMPLEX TRADING, LLC | 47,600 | $3,943,000 | 0.00% |
| JPMORGAN CHASE & CO | 53,900 | $4,466,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |